Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Andrew Atkinson is active.

Publication


Featured researches published by Andrew Atkinson.


Infection Control and Hospital Epidemiology | 2016

National Bloodstream Infection Surveillance in Switzerland 2008-2014: Different Patterns and Trends for University and Community Hospitals.

Niccolò Buetti; Jonas Marschall; Andrew Atkinson; Andreas Kronenberg

OBJECTIVE To characterize the epidemiology of bloodstream infections in Switzerland, comparing selected pathogens in community and university hospitals. DESIGN Observational, retrospective, multicenter laboratory surveillance study. METHODS Data on bloodstream infections from 2008 through 2014 were obtained from the Swiss infection surveillance system, which is part of the Swiss Centre for Antibiotic Resistance (ANRESIS). We compared pathogen prevalences across 26 acute care hospitals. A subanalysis for community-acquired and hospital-acquired bloodstream infections in community and university hospitals was performed. RESULTS A total of 42,802 bloodstream infection episodes were analyzed. The most common etiologies were Escherichia coli (28.3%), Staphylococcus aureus (12.4%), and polymicrobial bloodstream infections (11.4%). The proportion of E. coli increased from 27.5% in 2008 to 29.6% in 2014 (P = .04). E. coli and S. aureus were more commonly reported in community than university hospitals (34.3% vs 22.7%, P<.001 and 13.9% vs 11.1%, P<.001, respectively). Fifty percent of episodes were community-acquired, with E. coli again being more common in community hospitals (41.0% vs 32.4%, P<.001). The proportion of E. coli in community-acquired bloodstream infections increased in community hospitals only. Community-acquired polymicrobial infections (9.9% vs 5.6%, P<.001) and community-acquired coagulase-negative staphylococci (6.7% vs 3.4%, P<0.001) were more prevalent in university hospitals. CONCLUSIONS The role of E. coli as predominant pathogen in bloodstream infections has become more pronounced. There are distinct patterns in community and university hospitals, potentially influencing empirical antibiotic treatment. Infect Control Hosp Epidemiol 2016;37:1060-1067.


BMJ Open | 2017

Incidence of bloodstream infections: a nationwide surveillance of acute care hospitals in Switzerland 2008-2014.

Niccolò Buetti; Andrew Atkinson; Jonas Marschall; Andreas Kronenberg

Background Bloodstream infections are often associated with significant mortality and morbidity. We aimed to investigate changes in the epidemiology of bloodstream infections in Switzerland between 2008 and 2014. Methods Data on bloodstream infections were obtained from the Swiss antibiotic resistance surveillance system (ANRESIS). Results The incidence of bloodstream infections increased throughout the study period, especially among elderly patients and those receiving care in emergency departments and university hospitals. Escherichia coli was the predominant pathogen, with Enterococci exhibiting the most prominent increase over the study period. Conclusions The described trends may impact morbidity, mortality and healthcare costs associated with bloodstream infections.


Infection Control and Hospital Epidemiology | 2016

Handrub Consumption Mirrors Hand Hygiene Compliance.

Sebastian Haubitz; Andrew Atkinson; Tanja Kaspar; Doris Nydegger; Anne Eichenberger; Rami Sommerstein; Jonas Marschall

We assessed handrub consumption as a surrogate marker for hand hygiene compliance from 2007 to 2014. Handrub consumption varied substantially between departments but correlated in a mixed effects regression model with the number of patient-days and the observed hand hygiene compliance. Handrub consumption may supplement traditional hand hygiene observations. Infect Control Hosp Epidemiol 2016;37:707-710.


Clinical Infectious Diseases | 2017

Impact of tenofovir on hepatitis delta virus replication in the Swiss HIV Cohort Study.

Charles Antoine Béguelin; Nicole Friolet; Darius Moradpour; Roland Sahli; Franziska Marta Suter; Alexander Lüthi; Matthias Cavassini; Huldrych F. Günthard; Manuel Battegay; Enos Bernasconi; Patrick Schmid; Alexandra Calmy; Andrew Atkinson; Andri Rauch; Gilles Wandeler

We analyzed changes in hepatitis B virus and hepatitis delta virus (HDV) viral loads (VL) during tenofovir-containing antiretroviral therapy among patients with a replicating HDV infection in the Swiss HIV Cohort Study. Only 28.6% experienced a ≥2.0 log reduction in HDV RNA, and 14.3% had undetectable HDV VL within 5 years.


Clinical Infectious Diseases | 2017

Impact of Tenofovir on Hepatitis Delta Virus Replication in the Swiss Human Immunodeficiency Virus Cohort Study

Charles Antoine Béguelin; Nicole Friolet; Darius Moradpour; Roland Sahli; Franziska Suter-Riniker; Alexander Lüthi; Matthias Cavassini; Huldrych F. Günthard; Manuel Battegay; Enos Bernasconi; Patrick Schmid; Alexandra Calmy; Andrew Atkinson; Andri Rauch; Gilles Wandeler

We analyzed changes in hepatitis B virus and hepatitis delta virus (HDV) viral loads (VL) during tenofovir-containing antiretroviral therapy among patients with a replicating HDV infection in the Swiss HIV Cohort Study. Only 28.6% experienced a ≥2.0 log reduction in HDV RNA, and 14.3% had undetectable HDV VL within 5 years.


Critical Care | 2018

Epidemiology of subsequent bloodstream infections in the ICU

Niccolò Buetti; Elia Lo Priore; Rami Sommerstein; Andrew Atkinson; Andreas Kronenberg; Jonas Marschall

Subsequent bloodstream infections (sBSI) occur with a delay after removal of the intravascular catheter (IVC) whose tip revealed microbial growth. Here we describe the epidemiology of sBSI in the intensive care setting. Serratia marcescens, Staphylococcus aureus, Pseudomonas aeruginosa, and yeast were the pathogens most frequently associated with sBSI. In contrast, Enterococci were rarely found in sBSI.


Clinical Microbiology and Infection | 2018

Characterizing non-linear effects of hospitalisation duration on antimicrobial resistance in respiratory isolates: an analysis of a prospective nationwide surveillance system

Rami Sommerstein; Andrew Atkinson; E. Lo Priore; Andreas Kronenberg; Jonas Marschall; A. Burnens; Abdessalam Cherkaoui; O. Dubuis; Adrian Egli; V. Gaia; D. Koch; Stephen L. Leib; S. Luyet; Patrice Nordmann; V. Perreten; J.-C. Piffaretti; G. Prod’hom; Jacques Schrenzel; Andreas F. Widmer; Giorgio Zanetti; Reinhard Zbinden

OBJECTIVES Our objective was to systematically study the influence of length of hospital stay on bacterial resistance in relevant respiratory tract isolates. METHODS Using prospective epidemiological data from the National Swiss Antibiotic Resistance Surveillance System, susceptibility testing results for respiratory isolates retrospectively retrieved from patients hospitalised between 2008 and 2014 were compiled. Generalized additive models were used to illustrate resistance rates relative to hospitalisation duration and to adjust for co-variables. RESULTS In all, 19 622 isolates of six relevant and predominant species were included. Resistance patterns for the predominant species showed a species-specific and antibiotic-resistance-specific profile in function of hospitalisation duration. The oxacillin resistance profile in Staphylococcus aureus isolates was constantly increasing (monophasic). The pattern of resistance to cefepime in Pseudomonas aeruginosa was biphasic with a decreasing resistance rate for the first 5 days of hospitalisation and an increase for days 6-30. A different biphasic pattern occurred in Escherichia coli regarding amoxicillin-clavulanic acid resistance: odds/day increased for the first 7 days of hospitalisation and then remained stable for days 8-30. In the adjusted models epidemiological characteristics such as age, ward type, hospital type and linguistic region were identified as relevant co-variables for the resistance rates. The contribution of these confounders was specific to the individual species/antibiotic resistance models. CONCLUSIONS Resistance rates do not follow a dichotomic pattern (early versus late nosocomial) as suggested by current hospital-acquired pneumonia treatment guidelines. Duration of hospitalisation rather appears to have a more complex and non-linear relationship with bacterial resistance in hospital-acquired pneumonia, also depending on host and environmental factors.


Journal of the International AIDS Society | 2017

HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies

Lukas Fenner; Andrew Atkinson; Andrew Boulle; Matthew P. Fox; Hans Prozesky; Kathrin Zürcher; Marie Ballif; Hansjakob Furrer; Marcel Zwahlen; Mary-Ann Davies; Matthias Egger

Introduction: Chronic immune activation due to ongoing HIV replication may lead to impaired immune responses against opportunistic infections such as tuberculosis (TB). We studied the role of HIV replication as a risk factor for incident TB after starting antiretroviral therapy (ART).


Antimicrobial Resistance and Infection Control | 2017

Knowledge sharing in infection prevention in routine and outbreak situations: a survey of the Society for Healthcare Epidemiology of America Research Network

Rami Sommerstein; Sonja Geser; Andrew Atkinson; Franziska Tschan; Daniel J. Morgan; Jonas Marschall

In this cross-sectional Society for Healthcare Epidemiology of America Research Network survey on knowledge sharing in infection prevention we identified a rudimentary understanding of how to communicate and share knowledge within healthcare institutions. Our data support the need of further research in this important field.


Open Forum Infectious Diseases | 2015

National bloodstream infection surveillance in Switzerland 2008-2014: Patterns and trends differ between university and community hospitals

Niccolò Buetti; Jonas Marschall; Andrew Atkinson; Andreas Kronenberg

Background: In light of the recently described shift in bloodstream infections towards Gram-negative bacteria, we wanted to elucidate the epidemiology of bloodstream infections in Switzerland, comparing selected pathogens in both community (CH) and university hospitals (UH). Methods: Data on bloodstream infections from 2008 to 2014 were obtained from the representative Swiss infection surveillance system ANRESIS. Using descriptive statistics we compared pathogen prevalence over time in all 26 participating acute care hospitals. We performed a subanalysis of community-acquired (CA) and hospital-acquired (HA) bloodstream infections in CH and UH. Results: We analyzed a total of 42’802 bloodstream infection episodes. The most common etiologies were E. coli (28.3%), S. aureus (12.4%) and polymicrobial bloodstream infections (11.4%). The proportion of E.coli increased from 27.5% in 2008 to 29.6% in 2014 (p=0.04). E. coli and S. aureus were more commonly reported in CH (34.3% vs 22.7%, p<0.001 and 13.9% vs 11.1%, p<0.001, respectively). Fifty percent (21’308) of episodes were CA, with E. coli again being more common in CHs (41.0% vs 32.4%, p<0.001). The proportion of E. coli in CA bloodstream infections even increased over time in CH. In contrast, CApolymicrobial infections (9.9% vs 5.6%, p<0.001) and CA-CoNS (6.7% vs 3.4%, p<0.001) were more prevalent in UH, and their frequency in UH was more pronounced in the HA subset of bloodstream infections. Conclusion: E. coli’s role as predominant pathogen in bloodstream infections in Switzerland has recently become more pronounced. There are distinct patterns in CHs and UHs, potentially influencing empiric antibiotic treatment.

Collaboration


Dive into the Andrew Atkinson's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge